Document And Entity Information
Document And Entity Information | Nov. 10, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 10, 2022 |
Entity Registrant Name | Finch Therapeutics Group, Inc. |
Entity Central Index Key | 0001733257 |
Entity Emerging Growth Company | true |
Securities Act File Number | 001-40227 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 82-3433558 |
Entity Address, Address Line One | 200 Inner Belt Road |
Entity Address, City or Town | Somerville |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02143 |
City Area Code | (617) |
Local Phone Number | 229-6499 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | false |
Title of 12(b) Security | Common Stock $0.001 par value per share |
Trading Symbol | FNCH |
Security Exchange Name | NASDAQ |